| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NANOSTRING TECHNOLOGIES INC | 3,959,440 | 88,296,000 | 58.16% | ||
| 2 | SIENTRA INC | 2,730,765 | 23,266,000 | 15.32% | ||
| 3 | Oxford Immunotec Global PLC | 1,159,425 | 17,333,000 | 11.42% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,752,488 | 9,937,000 | 6.55% | ||
| 5 | VBI VACCINES INC COM NEW | 2,691,042 | 8,342,000 | 5.49% | ||
| 6 | ESSA Pharma | 2,121,212 | 4,645,000 | 3.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-17-000112, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
